Business · 06/08/2003Updated: 10/17/2026 · 1 min read
FDA and NIAID Host Public Workshop on Febrile Neutropenia and Antifungal Combination Therapy
Summary
The FDA, in collaboration with NIAID, is hosting a public workshop to gather input from various stakeholders on the clinical trial design for treating febrile neutropenia and antifungal combination therapy, with the goal of informing drug development in this area.